(Q43747294)

26 November 2017

Adrenocortical carcinoma. Clinical outcome at the end of the 20th century (English)

1 reference

26 November 2017

Vassilopoulou-Sellin R

series ordinal

1

1 reference

PubMed ID

11571723

26 November 2017

Schultz PN

series ordinal

2

1 reference

PubMed ID

11571723

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

92

1 reference

26 November 2017

5

1 reference

26 November 2017

1113-1121

1 reference

Adrenal cortical carcinoma. Clinical features of 138 patients

26 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Adrenal cortical carcinoma. A clinical and pathologic study of 49 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

The clinical and pathologic featurfs of “non-hormonal” adrenocortical tumors.Report of twenty new cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Adrenal cortical neoplasms. A study of 56 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Prognostic factors in adrenal cortical tumors. A mathematical analysis of clinical and morphologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Survival rates and prognostic factors in adrenocortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Adrenal cortical carcinoma in Norway, 1970-1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

The Cleveland Clinic experience with adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Surgical management, DNA content, and patient survival in adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Morphologic characteristics of benign and malignant adrenocortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Adrenal cortical carcinoma. A study of 77 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Adrenal cortical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010901%2992%3A5%3C1113%3A%3AAID-CNCR1428%3E3.0.CO%3B2-I

10.1002/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11571723